US Patent Issued to MEDRX on Oct. 14 for "Double stranded RNA specifically inhibiting expression of IL-23 and pharmaceutical composition comprising same" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,442,001, issued on Oct. 14, was assigned to MEDRX Co. LTD. (Kagawa, Japan).

"Double stranded RNA specifically inhibiting expression of IL-23 and pharmaceutical composition comprising same" was invented by Yasushi Miwa (Higashikagawa, Japan), Hidetoshi Hamamoto (Higashikagawa, Japan) and Tatsuhiro Ishida (Tokushima, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a novel siRNA specifically inhibiting the expression of IL-23 and a pharmaceutical composition comprising the siRNA specifically a double stranded RNA comprising a sense strand an antisense strand wherein each strand has 19 to 30 nucleotides and comprises the ...